A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas

NCT00766467 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Malignant Glioma

Interventions

DRUG: Armodafinil
OTHER: Placebo

Sponsor

Eudocia Quant Lee, MD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]